Yes: The american academy of neurology has issued an about lack of value of interferons and Copaxone in the treatment of secondary progressive ms, so not worthwhile to continue. However, there are newer oral meds, especially gilenya, (fingolimod) which may have promise with spms. Research studies may be available. Do monitor your vitamin d intake, and get about 5-10, 000 units daily.
Answered 6/24/2014
4.9k views
A doctor has provided 1 answer
5 doctors weighed in across 2 answers
6 doctors weighed in across 3 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question